Health Related Quality of Life in LCIG Patients and LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy. A Multicenter Post Marketing Observational Study for LCIG in Germany and Switzerland - BALANCE
Phase of Trial: Phase IV
Latest Information Update: 01 Nov 2017
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms BALANCE
- Sponsors AbbVie
- 02 Jun 2017 Planned number of patients changed from 250 to 266.
- 02 Jun 2017 Planned End Date changed from 1 Feb 2018 to 16 Dec 2018.
- 02 Jun 2017 Planned primary completion date changed from 1 Feb 2018 to 16 Dec 2018.